S&P BSE SENSEX (999901.BO)

Close: 79 213.00 (-588.90), Apr 25, 2025
Positive

Low risk

Automatic technical analysis. Long term, Apr 25, 2025

S&P BSE SENSEX is in a rising trend channel in the long term. This shows that investors over time have bought the index at higher prices and indicates good development for the market. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 73000 points. The index is assessed as technically positive for the long term.

Recommendation one to six quarters: Positive (Score: 93)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.61%0.00-0.74%
5 days0.002.12%0.00+0.84%
22 days0.005.36%0.00+3.75%
66 days0.0010.26%0.00+3.24%

More analyses of S&P BSE SENSEX

chart S&P BSE SENSEX (999901) Candlesticks 22 Days
Candlesticks
chart S&P BSE SENSEX (999901) Short term
Short term: Hold
chart S&P BSE SENSEX (999901) Medium term
Medium term: Hold
chart S&P BSE SENSEX (999901) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.